DEBORAH WATERHOUSE

CEO, ViiV Healthcare and President, Global Health, GSK

Deborah Waterhouse was appointed to the GSK Leadership Team on 8 January 2020. She became Chief Executive Officer of ViiV Healthcare on 1 April 2017. ViiV Healthcare is majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders. In addition to leadership of the HIV business, she also leads GSK's Global Health organisation.

Deborah joined GSK in 1996 and was most recently the Senior Vice President of Primary Care within the company’s US business, prior to which she led the US Vaccines business.

She brings a wealth of experience to GSK having lived and worked in Europe, Asia Pacific and the USA, and a strong track record of performance in both speciality and primary care.

Deborah led the HIV business in the UK before heading the HIV Centre of Excellence for Pharma Europe, and held international roles as General Manager of Australia and New Zealand and Senior Vice President for Central and Eastern Europe.

READ ARTICLES WRITTEN BY DEBORAH

Our Executive Team

Harmony Garges, Chief Medical Officer at ViiV Healthcare
Dr Harmony Garges

Chief Medical Officer

Read more
Kimberly Smith, Head of Research and Development, ViiV Healthcare
Dr Kimberly Smith

Head of Research and Development

Read more
Lynn Baxter, Head of North America, ViiV Healthcare
Lynn Baxter

Head of North America

Read more
Neil Wilkinson, Chief Financial Officer
Neil Wilkinson

Chief Financial Officer

Read more
Robert Bowers, Head of Global Commercial Strategy, ViiV Healthcare
Robert Bowers

Head of Global Commercial Strategy

Read more
Andrew Stewart, General Counsel and Chief Compliance Officer, ViiV Healthcare
Andrew Stewart

General Counsel and Chief Compliance Officer

Read more
Audrey Abernathy, Head of External Affairs and Communications ViiV Healthcare
Audrey Abernathy

Head of External Affairs and Communications

Read more
Lauren Carey, Head of International
Lauren Carey

Head of International

Read more

YOU MAY ALSO BE INTERESTED IN

We are ViiV Healthcare: 100% dedicated to HIV medicines and research and focused on people living with HIV and AIDS.

Together we are engaged in the HIV response throughout the world, supported by a team of over 1,100 dedicated ViiV Healthcare staff working across the globe.

Discover more about who we are, the work we do and what we're doing to advance HIV science, support the delivery of HIV treatment and care; and work with partners to address the stigma and discrimination faced by people living with HIV.

NP-GBL-HVX-COCO-220025

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.